fbpx

Our Reach

From the mountains of Nepal to the coast of Mozambique, we’re bridging inequities for people facing cancer around the world.

Africa & Middle East
9,628 cancer patients across 15 diseases through 82 treating physicians
Asia Pacific
654 cancer patients across 5 diseases through 44 treating physicians
Eastern Europe & Central Asia
4,685 cancer patients across 11 diseases through 19 treating physicians
Latin America
3,501 cancer patients across 9 diseases through 107 treating physicians
South Asia
13,360 cancer patients across 12 diseases through 293 treating physicians

Africa and the Middle East

When we know what we’re treating, we can proactively channel medicine and strengthen local healthcare systems. Our efforts include:

  • Adding new countries to our Solidarity Fund, which provides access to molecular diagnostic systems and test kits in under-resourced settings
  • Partnering with patient associations to identify diagnostic needs across Africa

In October 2023, the first patients began receiving HER2- HR+ advanced breast cancer treatment in Mozambique. The Humanitarian Partnership for Access to Critical Treatments (Humanitarian PACT) is currently supporting these efforts, with plans to expand.

Asia Pacific, Eastern Europe, and Central Asia

We successfully import cancer treatments into Asia Pacific by partnering with governments, healthcare practitioners, and patient associations. In Eastern Europe and Central Asia, since we first opened access to treatment, hundreds of chronic myeloid leukemia (CML) patients are now living beyond their initial diagnosis. Our efforts include:

  • Implementing the Max Schooling and Last Mile initiatives, with Max Schooling being a particularly innovative program that addresses the often-overlooked victims of chronic disease diagnoses
  • Bridging critical access to diagnostic systems and test kits to our partner institutions whose patients cannot afford to travel out of the country for a blood test

In March 2024, the first treatment for adult patients with chronic lymphocytic leukemia were administered in Armenia and Nepal. It’s part of a three-year collaboration with BeiGene to provide access to the medicine in 29 low- and middle-income countries.

Latin America

Outside of accessing treatment, the largest barrier patients face in their journey with cancer is understanding their disease and gaining emotional support. Our efforts include:

  • Guiding patients and their families through their treatment lifecycle with disease education and support
  • Empowering patients by partnering with local patient associations, cancer advocates, and healthcare professionals

In September 2019, 11 patients in Guatemala gained access to hope when a second-line treatment for CML was approved for importation by the country’s Ministry of Health. This achievement was made possible through our team and partner physicians’ relentless efforts and commitment to patients.

South Asia

Our team in South Asia organizes critical support group meetings for thousands of patients each year. Our efforts include:

  • Providing pathways for emotional and community support for patients facing cultural stigmatization
  • Hosting fundraisers and awareness campaigns through Chai for Cancer

We partner with Friends of Max, one of the largest patient associations in the world supporting those with CML and GIST in India. We provide a safe space for people living with cancer and their caregivers to connect with physicians and each other to help overcome stigma.

Take Action

Help bridge access to treatment for more cancer patients around the world.

Give hope this season

Support patients and families facing cancer around the world

Donate Now

This will close in 0 seconds